JP TSE 4569 Pharmaceutical

KYORIN Pharmaceutical Co., Ltd.

杏林製薬株式会社

Revenue

¥126B

≈ $799.3M

Net income

¥3.4B

≈ $21.8M

Income taxes paid

¥2.9B

≈ $18.1M

Total assets

¥195B

≈ $1.2B

Equity ratio

72.9%

Ranked #938 among listed Japanese companies by corporate taxes paid · effective tax rate 22.5%.

Share price at fiscal year-end: ¥1,645 · market capitalization ¥98.6B · P/E 27.4 · P/B 0.69

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥126B	¥3.4B	¥1.0B	¥2.9B	¥195B	¥142B	72.9%	EDINET (consol.)
Mar 2025	¥130B	¥9.1B	¥3.7B	¥1.3B	¥194B	¥136B	70.4%	EDINET (consol.)
Mar 2024	¥120B	¥5.5B	—	—	¥178B	¥131B	73.6%	EDINET (consol.)
Mar 2023	¥113B	¥4.7B	—	—	¥176B	¥125B	71.3%	EDINET (consol.)
Mar 2022	¥106B	¥3.9B	—	—	¥172B	¥125B	72.4%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.